Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients
The main cause of increased mortality in end-stage renal disease (ESRD) is cardiovascular disease (CVD). Complement factor H (CFH) may affect risk of CVD. Our study investigates a role of CFH Y402H polymorphism as a potential risk factor of CVD in a large group of patients. A group of 1200 patients...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 132(2009), 2 vom: 01. Aug., Seite 285-90
|
|---|
| 1. Verfasser: |
Buraczynska, Monika
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Ksiazek, Piotr,
Zukowski, Pawel,
Benedyk-Lorens, Ewa,
Orlowska-Kowalik, Grazyna |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2009
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Complement Factor H
80295-65-4 |
|---|